Evidence map›Paper›PMID 24625750›Full record

ArticlePloS one2014

Sequencing of a patient with balanced chromosome abnormalities and neurodevelopmental disease identifies disruption of multiple high risk loci by structural variation.

Jonathon Blake, Andrew Riddell, Susanne Theiss, Alexis Perez Gonzalez, Bettina Haase, Anna Jauch, Johannes W G Janssen, David Ibberson, Dinko Pavlinic, Ute Moog and 2 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Human inversions and their functional consequences.Briefings in functional genomics · 2015
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Jonathon BlakeGenomics Core Facility, EMBL Heidelberg, Heidelberg, Germany.
Andrew RiddellFlow Cytometry Core Facility, EMBL Heidelberg, Heidelberg, Germany.
Susanne TheissInstitute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
Alexis Perez GonzalezFlow Cytometry Core Facility, EMBL Heidelberg, Heidelberg, Germany.
Bettina HaaseGenomics Core Facility, EMBL Heidelberg, Heidelberg, Germany.
Anna JauchInstitute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
Johannes W G JanssenInstitute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
David IbbersonGenomics Core Facility, EMBL Heidelberg, Heidelberg, Germany; CellNetworks Sequencing Core Facility, University of Heidelberg, Heidelberg, Germany.
Dinko PavlinicGenomics Core Facility, EMBL Heidelberg, Heidelberg, Germany.
Ute MoogInstitute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
Vladimir BenesGenomics Core Facility, EMBL Heidelberg, Heidelberg, Germany.
Heiko RunzInstitute of Human Genetics, University of Heidelberg, Heidelberg, Germany; Molecular Medicine Partnership Unit (MMPU), University of Heidelberg/EMBL, Heidelberg, Germany.
Heidelberg University · DEEuropean Molecular Biology Laboratory · DEEuropean Molecular Biology Organization · DE

Funding

Wellcome Trust
6 · The paper itself

Abstract

Balanced chromosome abnormalities (BCAs) occur at a high frequency in healthy and diseased individuals, but cost-efficient strategies to identify BCAs and evaluate whether they contribute to a phenotype have not yet become widespread. Here we apply genome-wide mate-pair library sequencing to characterize structural variation in a patient with unclear neurodevelopmental disease (NDD) and complex de novo BCAs at the karyotype level. Nucleotide-level characterization of the clinically described BCA breakpoints revealed disruption of at least three NDD candidate genes (LINC00299, NUP205, PSMD14) that gave rise to abnormal mRNAs and could be assumed as disease-causing. However, unbiased genome-wide analysis of the sequencing data for cryptic structural variation was key to reveal an additional submicroscopic inversion that truncates the schizophrenia- and bipolar disorder-associated brain transcription factor ZNF804A as an equally likely NDD-driving gene. Deep sequencing of fluorescent-sorted wild-type and derivative chromosomes confirmed the clinically undetected BCA. Moreover, deep sequencing further validated a high accuracy of mate-pair library sequencing to detect structural variants larger than 10 kB, proposing that this approach is powerful for clinical-grade genome-wide structural variant detection. Our study supports previous evidence for a role of ZNF804A in NDD and highlights the need for a more comprehensive assessment of structural variation in karyotypically abnormal individuals and patients with neurocognitive disease to avoid diagnostic deception.

Indexed as

Chromosome AberrationsBipolar DisorderChild, PreschoolConsanguinityGenetic VariationGenome-Wide Association StudyHumansIntelligence TestsKaryotypingKruppel-Like Transcription FactorsLanguage Development DisordersMagnetic Resonance ImagingMaleNeurodevelopmental DisordersProteasome Endopeptidase ComplexSchizophreniaKruppel-Like Transcription FactorsProteasome Endopeptidase ComplexPSMD14 protein, humanTrans-ActivatorsZNF804A protein, human

Identifiers

PMID24625750
PMCPMC3953210
OpenAlexW2081626265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.